Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Univec, Inc. is a medical device firm that, through its various operating divisions, develops, licenses, and sells products across the United States and internationally. Its primary offerings include a range of auto-disable and safety syringes. These encompass 1cc AD-syringes, which can be used for both aspirating and non-aspirating procedures, typically for dispensing precise doses of allergy, immunization, and insulin medications. Univec also produces sliding sheath syringes, engineered to protect both patients and healthcare professionals from accidental needlestick injuries. Additionally, the company manufactures bifurcated needle safety syringes, specifically designed for administering smallpox vaccines, particularly in response to potential bioterrorist threats. Univec distributes its auto-disable and sliding sheath safety syringes to private hospitals, other healthcare facilities, and distributors within the U.S., as well as to governmental entities in developing countries. Furthermore, it offers an online system that assists pharmaceutical companies with the marketing, fulfillment, and tracking of drug samples, serving as a connector between pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E.